Melanoma

Personalized mRNA Vaccines Reduce Melanoma Relapse Risk

Melanoma, a deadly form of skin cancer, has seen rising incidence worldwide, posing a significant health challenge . Recent advances in immunotherapy have transformed treatment options, with personalized mRNA vaccines emerging as a promising new approach to reduce melanoma relapse after surgery . These vaccines are designed uniquely for each patient’s tumor, harnessing the immune system to target residual cancer cells and improve survival outcomes .